Worldwide Healthcare News

Anesthesia and respiratory devices market accounted for $23,446 million in 2016, and is estimated to reach $38,298 million by 2023, registering a CAGR of 7.2% from 2017 to 2023. North America was the highest contributor in the anesthesia and respiratory devices market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Download the Sample Report @  http://bit.ly/2KchsjB Respiratory care is a healthcare specialty focused on improving cardiopulmonary functions and promoting health and wellness. Respiratory care devices are majorly classified into therapeutic, diagnostic & monitoring devices, and consumables & accessories. These devices are used to deal with medical conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and other acute & chronic respiratory diseases, in hospitals and homecare settings. Anesthesia is a medical procedure used to provide sedation to the patients using anesthetics t...

Breast biopsy market was valued at $977 million in 2016, and is projected to reach at $1,420 million by 2023, growing at a CAGR of 5.3% from 2017 to 2023. Core needle biopsy (CNB) segment accounted for about half of the global market share in 2016. Download the Sample Report @  http://bit.ly/2ZbTB82 A breast biopsy is the procedure of locating a diseased tissue in the breast and collecting the specimen sample of the area for further examination and diagnosis. Breast biopsies are performed by using minimally invasive biopsy systems, owing to minimal disfigurement and pain. Non-invasive biopsy techniques provide preventive measures that assist physicians in diagnosing and treating high-risk breast cancer. This information prevents the application of chemotherapy in breast cancer, reducing the complexities of chemo-radiations. Vacuum assisted breast biopsy devices (VAB), core needle biopsies and fine needle aspiration biopsy are commonly used to perform biopsy procedures. The ...

Global biomaterials market   is expected to reach $139 billion by 2022, from $62 billion in 2015, growing at a CAGR of 11.8% from 2016 to 2022, according to Allied Market Research. Metallic biomaterials segment is expected to contribute significantly to the global market revenue until 2022. North America held the leading position in the global market in 2015, and is expected to maintain its lead throughout the study period. Download the Sample Report @  http://bit.ly/2ZV0qLv Metallic biomaterials segment contributed the highest revenue share to the global market, owing to highly used in orthopedic treatments for bone support and replacement, due to their strength and resistance to fatigue degradation. Polymeric biomaterials segment is projected to grow at a CAGR of 13.0% from 2016 to 2022, due to increasing demand for biodegradable products, and their use in various applications due their unique features such as flexibility, lightweight, remarkable biocompatibility, and ...

Advanced wound care and wound closure products have emerged as a promising solution for faster wound healing. These solutions are superior to traditional wound healing products in terms of their ability to produce the desired result and effective in healing wounds. The rising incidences of chronic wounds have intensified the need for faster wound healing products. Thus, Hospitals have shifted their inclination towards the use of advanced wound care and closure products. Attempts to reduce hospital stays in order to limit surgical healthcare costs, and the rising demand for products that enhance therapeutic outcome are driving the advanced wound care and closure products' market. Download the Sample Report @  http://bit.ly/2JHJ1C1 Advanced Wound Care and Closure Market  Report, published by Allied Market Research, forecasts that the global market is expected to garner $20.5 billion by 2020, registering a CAGR of 8.0% during the period 2014-2020.The study of wound closure ...